Literature DB >> 25083266

Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety.

Cameron J Phillips1.   

Abstract

Entities:  

Year:  2014        PMID： 25083266      PMCID： PMC4110855          DOI： 10.1177/2042098614523819

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  20 in total

Review 1.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

2.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

3.  Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system.

Authors:  Lauren McCluggage; Kimberly Lee; Teresa Potter; Richard Dugger; Amy Pakyz
Journal:  Am J Health Syst Pharm       Date:  2010-01-01       Impact factor: 2.637

4.  Why monitor peak vancomycin concentrations?

Authors:  N J Saunders
Journal:  Lancet       Date:  1994 Dec 24-31       Impact factor: 79.321

5.  Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.

Authors:  Yosuke Suzuki; Kanako Kawasaki; Yuhki Sato; Issei Tokimatsu; Hiroki Itoh; Kazufumi Hiramatsu; Masaharu Takeyama; Jun-Ichi Kadota
Journal:  Chemotherapy       Date:  2012-11-07       Impact factor: 2.544

6.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Vancomycin: we can't get there from here.

Authors:  Nimish Patel; Manjunath P Pai; Keith A Rodvold; Ben Lomaestro; George L Drusano; Thomas P Lodise
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

Review 8.  Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.

Authors:  Christopher Giuliano; Christopher Giulano; Krystal K Haase; Ronald Hall
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

Review 9.  Vancomycin therapeutics and monitoring: a contemporary approach.

Authors:  M L Avent; V L Vaska; B A Rogers; A C Cheng; S J van Hal; N E Holmes; B P Howden; D L Paterson
Journal:  Intern Med J       Date:  2013-02       Impact factor: 2.048

Review 10.  Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.

Authors:  Zhi-Kang Ye; Hui-Lin Tang; Suo-Di Zhai
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240
View more
  2 in total

1.  Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen.

Authors:  S Cristea; K Allegaert; A C Falcao; F Falcao; R Silva; A Smits; C A J Knibbe; E H J Krekels
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Validation of Vancomycin Area under the Concentration-Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  Takashi Ueda; Yoshio Takesue; Kazuhiko Nakajima; Kaoru Ichiki; Kaori Ishikawa; Kumiko Yamada; Toshie Tsuchida; Naruhito Otani; Yoshiko Takahashi; Mika Ishihara; Shingo Takubo; Hiroki Ikeuchi; Motoi Uchino; Toshimi Kimura; Kazuaki Matsumoto; Kazutaka Oda; Takeshi Kimura
Journal:  Antibiotics (Basel)       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.